Stockreport

IGM Biosciences Announces Strategic Pivot to Focus Exclusively on Autoimmunity

IGM Biosciences, Inc.  (IGMS) 
Last igm biosciences, inc. earnings: 3/26 04:05 pm Check Earnings Report
PDF – Company to prioritize its pipeline of T cell engagers in autoimmune diseases, including ongoing clinical development of imvotamab in rheumatoid arthritis and systemic [Read more]